These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 30915735)

  • 21. Reciprocal regulation of long noncoding RNAs THBS4‑003 and THBS4 control migration and invasion in prostate cancer cell lines.
    Liu J; Cheng G; Yang H; Deng X; Qin C; Hua L; Yin C
    Mol Med Rep; 2016 Aug; 14(2):1451-8. PubMed ID: 27357608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
    Guo Z; Liu D; Su Z
    Tumour Biol; 2015 Jun; 36(6):4777-83. PubMed ID: 25636449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EHMT2 promotes the development of prostate cancer by inhibiting PI3K/AKT/mTOR pathway.
    Fan HT; Shi YY; Lin Y; Yang XP
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7808-7815. PubMed ID: 31599405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of endonuclease domain-containing 1 as a novel tumor suppressor in prostate cancer.
    Qiu J; Peng S; Si-Tu J; Hu C; Huang W; Mao Y; Qiu W; Li K; Wang D
    BMC Cancer; 2017 May; 17(1):360. PubMed ID: 28532481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
    Li X; Han X; Wei P; Yang J; Sun J
    Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer.
    Wang X; Shi Z; Liu X; Su Y; Li W; Dong H; Zhao L; Li M; Wang Y; Jin X; Huo Z
    J BUON; 2018; 23(2):444-452. PubMed ID: 29745091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SP1-mediated upregulation of lncRNA SNHG4 functions as a ceRNA for miR-377 to facilitate prostate cancer progression through regulation of ZIC5.
    Wang ZY; Duan Y; Wang P
    J Cell Physiol; 2020 Apr; 235(4):3916-3927. PubMed ID: 31608997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer.
    Guo Z; He C; Yang F; Qin L; Lu X; Wu J
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31481527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down regulation of lncRNA MEG3 promotes colorectal adenocarcinoma cell proliferation and inhibits the apoptosis by up-regulating TGF-β1 and its downstream sphingosine kinase 1.
    Dong X; Wang J; Li T; Xu YP; Li SY
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8265-8272. PubMed ID: 30556866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of N-myc downstream-regulated gene 2 in prostatic carcinoma.
    Yu C; Wu G; Dang N; Zhang W; Zhang R; Yan W; Zhao Y; Gao L; Wang Y; Beckwith N; Yuan J; Yao L
    Cancer Biol Ther; 2011 Aug; 12(4):304-13. PubMed ID: 21623166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
    Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
    Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long noncoding RNA TUG1 regulates the development of oral squamous cell carcinoma through sponging miR-524-5p to mediate DLX1 expression as a competitive endogenous RNA.
    Liu S; Liu LH; Hu WW; Wang M
    J Cell Physiol; 2019 Nov; 234(11):20206-20216. PubMed ID: 30980391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long noncoding RNA Linc00662 promotes the tumorigenesis of prostate cancer cells].
    Yao ZF; Pan ZY; Yao YW; Chen JF
    Zhonghua Nan Ke Xue; 2020 Jul; 26(7):588-594. PubMed ID: 33377712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer.
    Mengus C; Le Magnen C; Trella E; Yousef K; Bubendorf L; Provenzano M; Bachmann A; Heberer M; Spagnoli GC; Wyler S
    J Transl Med; 2011 Sep; 9():162. PubMed ID: 21943235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTPIP51 mRNA and protein expression in tissue microarrays and promoter methylation of benign prostate hyperplasia and prostate carcinoma.
    Koch P; Petri M; Paradowska A; Stenzinger A; Sturm K; Steger K; Wimmer M
    Prostate; 2009 Dec; 69(16):1751-62. PubMed ID: 19691131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-cell sequencing analysis revealed that NEAT1 was a potential biomarker and therapeutic target of prostate cancer.
    Li X; Li Y; Zhang L; Long H
    BMC Cancer; 2024 Oct; 24(1):1242. PubMed ID: 39379919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of long noncoding RNA LINC01358 in prostate cancer and its effect on the proliferation and migration of prostate cancer cells].
    Xu B; Chen SQ; Liu N; Lu K; Wang YD; Sun C; Jiang H; Yang Y; Zhang XW; Xu B; Liu J; Zhu WD; Chen M
    Zhonghua Nan Ke Xue; 2016 Dec; 22(12):1083-1087. PubMed ID: 29282912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long Non-Coding RNA Taurine Upregulated Gene 1 (TUG1) Downregulation Constrains Cell Proliferation and Invasion through Regulating Cell Division Cycle 42 (CDC42) Expression Via MiR-498 in Esophageal Squamous Cell Carcinoma Cells.
    Wang Z; Liu J; Wang R; Wang Q; Liang R; Tang J
    Med Sci Monit; 2020 Mar; 26():e919714. PubMed ID: 32139664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9.
    Tan SF; Ni JX; Xiong H
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2271-2280. PubMed ID: 32196578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway.
    Song X; Wang H; Wu J; Sun Y
    Cancer Biother Radiopharm; 2020 Nov; 35(9):682-695. PubMed ID: 32407168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.